Alkermes plc (ALKS)
Biotechnology · Healthcare · $7.4B
Intrinsic Value (Consensus)
$24.46
Current Price
$44.28
Margin of Safety
-44.8%
44.8% Above Intrinsic Value
Value: $24
Price: $44
Valuation Model Estimates
Current Price: $44.28
DCF (Discounted Cash Flow)
$36.59
Graham Number
$18.75
Earnings Power Value
$13.88
Relative Value (P/E)
$28.60
Dividend Discount Model
Not applicable
—
Consensus Value
$24.46
Model Assumptions
Discount Rate
10.3%
Growth Rate
2.0%
Terminal Growth
2.5%
Risk-Free Rate
4.3%
Discount rate derived from CAPM (risk-free rate + beta × market risk premium). Growth rate based on trailing earnings growth, capped at 20%.
Key Financials
- EPS (TTM)
- $1.43
- EPS (Forward)
- $1.46
- Book Value
- $10.93
- P/E Ratio
- 20.0
- Forward P/E
- 19.6
- PEG Ratio
- —
- ROE
- 13.3%
- Debt/Equity
- 16%
- Revenue Growth
- -5.2%
- Earnings Growth
- 2.0%
- Dividend Yield
- N/A
- Beta
- 0.33
Data last updated: 2026-06-12
Source: Yahoo Finance